HUP0000907A3 - Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives - Google Patents

Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives

Info

Publication number
HUP0000907A3
HUP0000907A3 HU0000907A HUP0000907A HUP0000907A3 HU P0000907 A3 HUP0000907 A3 HU P0000907A3 HU 0000907 A HU0000907 A HU 0000907A HU P0000907 A HUP0000907 A HU P0000907A HU P0000907 A3 HUP0000907 A3 HU P0000907A3
Authority
HU
Hungary
Prior art keywords
pyrazolo
oxo
preparing
pyridine derivatives
pyridine
Prior art date
Application number
HU0000907A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0000907D0 publication Critical patent/HU0000907D0/hu
Publication of HUP0000907A2 publication Critical patent/HUP0000907A2/hu
Publication of HUP0000907A3 publication Critical patent/HUP0000907A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0000907A 1999-02-26 2000-02-25 Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives HUP0000907A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (3)

Publication Number Publication Date
HU0000907D0 HU0000907D0 (en) 2000-04-28
HUP0000907A2 HUP0000907A2 (en) 2001-03-28
HUP0000907A3 true HUP0000907A3 (en) 2001-05-28

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000907A HUP0000907A3 (en) 1999-02-26 2000-02-25 Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives

Country Status (44)

Country Link
US (2) US6541634B2 (hu)
EP (2) EP1031575B1 (hu)
JP (3) JP3437813B2 (hu)
KR (2) KR100372063B1 (hu)
CN (3) CN1515570A (hu)
AP (1) AP1221A (hu)
AR (2) AR029617A1 (hu)
AT (1) ATE277944T1 (hu)
AU (1) AU764122B2 (hu)
BG (1) BG104175A (hu)
BR (2) BRPI0017522B8 (hu)
CA (1) CA2299495C (hu)
CO (1) CO5160252A1 (hu)
DE (1) DE60014212T2 (hu)
DK (1) DK1031575T3 (hu)
DZ (1) DZ3018A1 (hu)
EA (1) EA003218B1 (hu)
EE (1) EE200000193A (hu)
ES (1) ES2226712T3 (hu)
GT (1) GT200000018A (hu)
HK (1) HK1030219A1 (hu)
HN (1) HN2000000021A (hu)
HR (1) HRP20000103A2 (hu)
HU (1) HUP0000907A3 (hu)
ID (1) ID24861A (hu)
IL (2) IL134599A (hu)
IN (1) IN192352B (hu)
IS (1) IS5380A (hu)
MA (1) MA25072A1 (hu)
NO (1) NO20000965L (hu)
NZ (1) NZ503062A (hu)
OA (1) OA11325A (hu)
PA (1) PA8491201A1 (hu)
PE (1) PE20001550A1 (hu)
PL (1) PL338628A1 (hu)
PT (1) PT1031575E (hu)
SG (1) SG90096A1 (hu)
SI (1) SI1031575T1 (hu)
SK (1) SK284982B6 (hu)
TN (1) TNSN00035A1 (hu)
TR (1) TR200000536A2 (hu)
TW (2) TWI286142B (hu)
UA (1) UA70306C2 (hu)
ZA (1) ZA200000888B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
JP2003534377A (ja) 2000-05-30 2003-11-18 メルク エンド カムパニー インコーポレーテッド メラノコルチン受容体作働薬
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
US9499543B2 (en) * 2013-05-28 2016-11-22 Raqualia Pharma Inc. Polymorph forms
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
CA2175218A1 (en) 1993-11-09 1995-05-18 Gregori J. Morriello Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
USRE38524E1 (en) 1997-06-25 2004-06-01 Pfizer Inc. Dipeptide derivatives as growth hormone secretagogues
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
TWI286142B (en) 2007-09-01
HN2000000021A (es) 2001-02-02
ATE277944T1 (de) 2004-10-15
KR20010006698A (ko) 2001-01-26
PA8491201A1 (es) 2001-04-30
BG104175A (bg) 2000-12-29
NO20000965L (no) 2000-08-28
CN1515570A (zh) 2004-07-28
US6541634B2 (en) 2003-04-01
TNSN00035A1 (fr) 2005-11-10
ES2226712T3 (es) 2005-04-01
PL338628A1 (en) 2000-08-28
TW200718702A (en) 2007-05-16
DZ3018A1 (fr) 2004-03-20
KR100372063B1 (ko) 2003-02-14
SK2302000A3 (en) 2000-11-07
EP1031575A1 (en) 2000-08-30
NZ503062A (en) 2001-07-27
HU0000907D0 (en) 2000-04-28
KR20020065455A (ko) 2002-08-13
UA70306C2 (en) 2004-10-15
CN1837205A (zh) 2006-09-27
TR200000536A2 (tr) 2000-09-21
DE60014212D1 (de) 2004-11-04
BRPI0017522B8 (pt) 2021-05-25
IL157103A (en) 2007-07-24
HK1030219A1 (en) 2001-04-27
ZA200000888B (en) 2001-08-23
PT1031575E (pt) 2004-11-30
CA2299495A1 (en) 2000-08-26
KR100361783B1 (ko) 2002-11-22
DK1031575T3 (da) 2005-01-03
SG90096A1 (en) 2002-07-23
PE20001550A1 (es) 2001-01-11
US20030158414A1 (en) 2003-08-21
JP2000247974A (ja) 2000-09-12
IL134599A0 (en) 2001-04-30
BRPI0017522A2 (hu) 2009-12-22
JP3437813B2 (ja) 2003-08-18
DE60014212T2 (de) 2005-12-15
NO20000965D0 (no) 2000-02-25
JP2003327585A (ja) 2003-11-19
BRPI0000967B8 (pt) 2021-12-07
HRP20000103A2 (en) 2001-04-30
AR029617A1 (es) 2003-07-10
CO5160252A1 (es) 2002-05-30
ID24861A (id) 2000-08-31
CA2299495C (en) 2010-06-15
HUP0000907A2 (en) 2001-03-28
JP4051314B2 (ja) 2008-02-20
OA11325A (en) 2003-10-27
US20020002283A1 (en) 2002-01-03
AR053722A2 (es) 2007-05-16
BRPI0000967B1 (pt) 2012-06-12
SI1031575T1 (en) 2005-02-28
AU1947100A (en) 2000-08-31
US6673929B2 (en) 2004-01-06
MA25072A1 (fr) 2000-10-01
IL157103A0 (en) 2004-02-08
BRPI0017522B1 (pt) 2013-09-24
AP2000001754A0 (en) 2000-03-31
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
IN192352B (hu) 2004-04-10
JP2003261565A (ja) 2003-09-19
CN1270960A (zh) 2000-10-25
AU764122B2 (en) 2003-08-07
EA003218B1 (ru) 2003-02-27
BRPI0000967A (pt) 2001-09-11
GT200000018A (es) 2001-08-16
EA200000172A3 (ru) 2000-10-30
EA200000172A2 (ru) 2000-08-28
IL134599A (en) 2006-12-10
EP1449842A1 (en) 2004-08-25
CN1137891C (zh) 2004-02-11
IS5380A (is) 2000-08-27
AP1221A (en) 2003-11-03
SK284982B6 (sk) 2006-03-02

Similar Documents

Publication Publication Date Title
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
HUP0201225A2 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
ZA200201511B (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents.
MXPA02001497A (es) Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales.
HUP9700885A3 (en) Novel process for producing thieno[3,2-c]pyridine derivatives
HUP0004747A3 (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
HUP0200144A3 (en) Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates
HUP0000907A2 (en) Process for preparing 3-oxo-pyrazolo-[4,3-c]pyridine derivatives
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
IL146810A0 (en) Process for preparing 10, 11-methanobenzosuberane derivatives
HUP0103778A3 (en) Process for preparing 1,5-diaryl-3-substituted pyrazoles
HK1020951A1 (en) Method for producing pyridine derivatives.
HU9802105D0 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
EG21526A (en) Improved process for preparing pharmaceutically useful norbenzomorphane derivatives
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
HUP0105224A2 (en) Process for preparing n6-substituted deaza-adenosine derivatives
ZA991576B (en) Process for the preparation of substituted pyridines.
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
IL143239A0 (en) Process for preparing pyridazin-3-on derivatives
HU0101332D0 (en) Process for preparing substituted pyridines
ZA200104182B (en) Process for preparing trichloroalkane derivatives.
ZA996624B (en) Process and intermediates for preparing nicotinamide derivatives.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees